Activation of Anaplastic Lymphoma Kinase Receptor Tyrosine Kinase Induces Neuronal Differentiation through the Mitogen-activated Protein Kinase Pathway

Boussad Souttou, Nicole Carvalho, D. Raulais, Marc Vigny

Journal of Biological Chemistry · 2001 · 127 citations · 25 references

DOIFull text

Open access

Concepts

Abstract

Anaplastic lymphoma kinase (ALK) is a novel neuronal orphan receptor tyrosine kinase that is essentially and transiently expressed in specific regions of the central and peripheral nervous systems, suggesting a role in its normal development and function. To determine whether ALK could play a role in neuronal differentiation, we established a model system that allowed us to mimic the normal activation of this receptor. We expressed, in PC12 cells, a chimeric protein in which the extracellular domain of the receptor was replaced by the mouse IgG 2b Fc domain. The Fc domain induced the dimerization and oligomerization of the chimeric protein leading to receptor phosphorylation and activation, thus mimicking the effect of ligand binding, whereas the wild type ALK remained as a monomeric nonphosphorylated protein. Expression of the chimera, but not that of the wild type ALK or of a kinase inactive form of the chimera, induced the differentiation of PC12 cells. Analysis of the signaling pathways involved in this process pointed to an essential role of the mitogen-activated protein kinase cascade. These results are consistent with a role for ALK in neuronal differentiation. Anaplastic lymphoma kinase (ALK) is a novel neuronal orphan receptor tyrosine kinase that is essentially and transiently expressed in specific regions of the central and peripheral nervous systems, suggesting a role in its normal development and function. To determine whether ALK could play a role in neuronal differentiation, we established a model system that allowed us to mimic the normal activation of this receptor. We expressed, in PC12 cells, a chimeric protein in which the extracellular domain of the receptor was replaced by the mouse IgG 2b Fc domain. The Fc domain induced the dimerization and oligomerization of the chimeric protein leading to receptor phosphorylation and activation, thus mimicking the effect of ligand binding, whereas the wild type ALK remained as a monomeric nonphosphorylated protein. Expression of the chimera, but not that of the wild type ALK or of a kinase inactive form of the chimera, induced the differentiation of PC12 cells. Analysis of the signaling pathways involved in this process pointed to an essential role of the mitogen-activated protein kinase cascade. These results are consistent with a role for ALK in neuronal differentiation. receptor tyrosine kinase anaplastic lymphoma kinase mitogen-activated protein kinase phosphoinositide-3 kinase phospholipase Cγ nucleophosmin nerve growth factor basic fibroblast growth factor base pair(s) polyacrylamide gel electrophoresis phosphate-buffered saline fluorescein isothiocyanate extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase/ERK kinase epidermal growth factor The common structural features of a receptor tyrosine kinase (RTK)1 include an extracellular ligand binding region, a hydrophobic membrane-spanning segment, and a cytoplasmic domain that carries the catalytic function. Following ligand binding, the RTK dimerizes and autophosphorylates (1Ullrich A. Schlessinger J. Cell. 1990; 61: 203-212Abstract Full Text PDF PubMed Scopus (4594) Google Scholar). The activated RTK initiates signal transduction cascades through binding of SH2 domain-containing proteins to specific receptor phosphotyrosine residues (2Pawson T. Nature. 1995; 373: 573-580Crossref PubMed Scopus (2222) Google Scholar). RTKs can regulate a wide variety of cellular processes involved in cell division, differentiation, survival, and motility. A number of RTKs play essential roles during the development of the nervous system by contributing to neuronal differentiation, survival, and function (reviewed in Ref. 3Henderson C.E. Curr. Opin. Neurobiol. 1996; 6: 64-70Crossref PubMed Scopus (256) Google Scholar). Most of these receptors have specific or shared ligands called neurotrophic factors that have been identified (reviewed in Ref. 3Henderson C.E. Curr. Opin. Neurobiol. 1996; 6: 64-70Crossref PubMed Scopus (256) Google Scholar). However, for some of them, named orphan receptors, their ligands are still unknown (4Ben-Neriah Y. Bauskin A.R. Nature. 1988; 333: 672-676Crossref PubMed Scopus (59) Google Scholar, 5Morris S.W. Naeve C. Mathew P. James P.L. Kirstein M.N. Cui X. Witte D.P. Oncogene. 1997; 14: 2175-2188Crossref PubMed Scopus (412) Google Scholar, 6Iwahara T. Fujimoto J. Wen D. Cupples R. Bucay N. Arakawa T. Mori S. Ratzkin B. Yamamoto T. Oncogene. 1997; 14: 439-449Crossref PubMed Scopus (548) Google Scholar). Anaplastic lymphoma kinase (ALK), a novel orphan neuronal receptor, was originally identified as a member of the insulin receptor subfamily of receptor tyrosine kinases that acquires transforming capability when truncated and fused in the t(2;5) chromosomal rearrangement associated with the non-Hodgkin lymphoma (7Morris S.W. Kirstein M.N. Valentine M.B. Dittmer K.G. Shapiro D.N. Saltman D.L. Look A.T. Science. 1994; 263: 1281-1284Crossref PubMed Scopus (1943) Google Scholar). This translocation produces a fusion gene that encodes a soluble chimeric transforming protein comprised of the N-terminal portion of the phosphoprotein nucleophosmin (NPM), a highly conserved RNA-binding nucleolar protein, linked to the cytoplasmic portion of ALK (7Morris S.W. Kirstein M.N. Valentine M.B. Dittmer K.G. Shapiro D.N. Saltman D.L. Look A.T. Science. 1994; 263: 1281-1284Crossref PubMed Scopus (1943) Google Scholar). The NPM-ALK fusion protein was localized within both the cytoplasm and the nucleoplasm and also within the nucleoli of t(2;5)-translocation-positive lymphoma cells (8Bischof D. Pulford K. Mason D.Y. Morris S.W. Mol. Cell. Biol. 1997; 17: 2312-2325Crossref PubMed Scopus (319) Google Scholar). However, whereas the NPM sequence is essential for the transforming activity (9Fujimoto J. Shiota M. Iwahara T. Seki N. Satoh H. Mori S. Yamamoto T. Proc. Natl. Acad. Sci. U. S. A. 1996; 93: 4181-4186Crossref PubMed Scopus (246) Google Scholar), the nuclear localization, occurring via the shuttling activity of NPM (10Chan W.Y. Liu Q.R. Borjigin J. Busch H. Rennert O.M. Tease L.A. Chan P.K. Biochemistry. 1989; 28: 1033-1039Crossref PubMed Scopus (261) Google Scholar), is not required for oncogenesis (11Borer R.A. Lehner C.F. Eppenberger H.M. Nigg E.A. Cell. 1989; 56: 379-390Abstract Full Text PDF PubMed Scopus (915) Google Scholar). It has been demonstrated that the NPM portion was responsible for the dimerization of the fusion protein leading to the constitutive activation of the kinase and to the transforming activity (8Bischof D. Pulford K. Mason D.Y. Morris S.W. Mol. Cell. Biol. 1997; 17: 2312-2325Crossref PubMed Scopus (319) Google Scholar). Human and mouse cDNAs encoding full-length ALK have been characterized (5Morris S.W. Naeve C. Mathew P. James P.L. Kirstein M.N. Cui X. Witte D.P. Oncogene. 1997; 14: 2175-2188Crossref PubMed Scopus (412) Google Scholar, 6Iwahara T. Fujimoto J. Wen D. Cupples R. Bucay N. Arakawa T. Mori S. Ratzkin B. Yamamoto T. Oncogene. 1997; 14: 439-449Crossref PubMed Scopus (548) Google Scholar). The deduced amino acid sequences revealed that ALK is a novel RTK having an extracellular domain, a single transmembrane domain, and an intracellular domain containing the tyrosine kinase activity. The open reading frame encodes a 1620-amino acid protein that is most closely related to leukocyte tyrosine kinase (4Ben-Neriah Y. Bauskin A.R. Nature. 1988; 333: 672-676Crossref PubMed Scopus (59) Google Scholar, 12Bernards A. de la Monte S.M. EMBO J. 1990; 9: 2279-2287Crossref PubMed Scopus (67) Google Scholar). Surface labeling studies indicated that the mature form of the receptor is a 200-kDa glycoprotein exposed at the cell membrane (5Morris S.W. Naeve C. Mathew P. James P.L. Kirstein M.N. Cui X. Witte D.P. Oncogene. 1997; 14: 2175-2188Crossref PubMed Scopus (412) Google Scholar), consistent with the prediction that ALK serves as the receptor for yet unidentified ligand(s). In situ hybridization analysis showed that ALK RNA is essentially and transiently expressed in specific regions of the central and peripheral nervous systems such as the thalamus, mid-brain, olfactory bulb, and peripheral ganglia and that it localizes mostly in neuronal cells (5Morris S.W. Naeve C. Mathew P. James P.L. Kirstein M.N. Cui X. Witte D.P. Oncogene. 1997; 14: 2175-2188Crossref PubMed Scopus (412) Google Scholar). The neonatal brain showed the highest expression, suggesting a possible involvement of ALK in development of the nervous system when axon sprouting and retraction are occurring. Because ALK expression is maintained, albeit at a lower level, in the adult brain, it may also play a role in synapse formation and maintenance (5Morris S.W. Naeve C. Mathew P. James P.L. Kirstein M.N. Cui X. Witte D.P. Oncogene. 1997; 14: 2175-2188Crossref PubMed Scopus (412) Google Scholar). Thus, ALK is a novel orphan receptor tyrosine kinase that might play an important role in the normal development and function of the nervous system. The ligand of ALK is unknown. Therefore, to investigate whether ALK can play a role in neuronal differentiation, we generated a constitutively active transmembrane form of ALK by substituting the extracellular domain of the receptor by the Fc fragment of mouse IgG 2b. We show here that the ALK.Fc protein expressed in PC12 cells dimerized, oligomerized, and was tyrosine-phosphorylated. Furthermore, we show that transient expression of ALK.Fc induced neuronal differentiation through the mitogen-activated protein (MAP) kinase pathway. PD98059 was obtained from New England BioLabs (Beverly, MA). Wortmannin was from Sigma (St. Quentin Fallavier, France). ET-18-OCH3 was purchased from Calbiochem (San Diego, CA). Nerve growth factor (NGF) was from Life Technologies (Cergy Pontoise, France) and basic fibroblast growth factor (bFGF) was a gift from F. Mascarelli (INSERM U450, Paris). Rabbit anti-ALK antibody was purchased from Accurate Chemicals Co. (Westbury, NY). Horseradish peroxidase-conjugated anti-mouse IgG was from Dako (Copenhagen, Denmark). Goat anti-P-MAPK antibody was obtained from UBI (Lake Placid, NY). Rabbit anti-phosphotyrosine antibody was from Transduction Laboratories (Lexington, KY). Rabbit anti-SCG10 antibody was a gift from S. Ozon (INSERM U440, Paris). The full-length human ALK cDNA in pBluescript was obtained from the American Tissue Culture Collection (ATCC). The cDNA, cut with XhoI-NotI and blunt-ended, was inserted at the EcoRV site of the mammalian expression vector pcDNA3.1 (Invitrogen, Groningen, The Netherlands) generating the pcDNA-ALK.wt construct. The cDNA, 6226 bp, covered the entire coding sequence of the protein. The ATG start codon is located at nucleotide position 912, the sequence coding for the transmembrane domain is located between nucleotides 4020 and 4083, and the stop codon is at position 5774. There is a HincII site at position 1079 and a PshAI site at position 3892. These sites were used to delete a major part of the ALK extracellular domain to generate the pcDNA-ALK.Fc construct (see below). The 864-bp PstI-EcoRV fragment of the mouse IgG 2b cDNA corresponding to the Fc fragment (GenBank™ accession number MMIGG7) in pBluescript was a gift from Dr. N. Doyen (Institut Pasteur, Paris). To construct the cDNA coding for the chimeric protein (pcDNA-ALK.Fc) containing extracellularly the mouse IgG 2b Fc domain linked to the membrane-spanning segment and the whole cytoplasmic domain of ALK, a polymerase chain reaction product corresponding to the entire sequence of the Fc fragment, flanked at the 5′-region with a HincII site and at the 3′-region with aPshAI site was produced and inserted at the same sites in the pcDNA-ALK.wt with its HincII-PshAI segment deleted. We prepared a kinase-defective form of the chimera (designated ALK*.Fc, and the corresponding construct was pcDNA-ALK*.Fc) in which the invariant lysine residue located in the ATP-binding portion of the catalytic domain was changed to arginine. This lysine residue, originally identified as residue 210 of the NPM-ALK fusion protein (7Morris S.W. Kirstein M.N. Valentine M.B. Dittmer K.G. Shapiro D.N. Saltman D.L. Look A.T. Science. 1994; 263: 1281-1284Crossref PubMed Scopus (1943) Google Scholar,8Bischof D. Pulford K. Mason D.Y. Morris S.W. Mol. Cell. Biol. 1997; 17: 2312-2325Crossref PubMed Scopus (319) Google Scholar), is located at position 1150 in ALK (5Morris S.W. Naeve C. Mathew P. James P.L. Kirstein M.N. Cui X. Witte D.P. Oncogene. 1997; 14: 2175-2188Crossref PubMed Scopus (412) Google Scholar, 6Iwahara T. Fujimoto J. Wen D. Cupples R. Bucay N. Arakawa T. Mori S. Ratzkin B. Yamamoto T. Oncogene. 1997; 14: 439-449Crossref PubMed Scopus (548) Google Scholar). The mutation was generated with the QuikChange site-directed mutagenesis kit (Stratagene Europe, Amsterdam, The Netherlands) using the sense oligonucleotide primer CTGCAAGTGGCTGTGAGGACGCTGCCTGAAGTG (in which theunderlined G replaced an A in the non-mutated sequence), together with the corresponding antisense oligonucleotide primer and the pcDNA-ALK.Fc construct as the template. This single base mutagenesis was verified by sequencing (Genset, France). The PC12 cell L.A. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar), purchased from was in with and at in an containing PC12 cells were using the as by the cells in of were with of and were to and In and these were with with growth PC12 cells were for in the of or of were and cells using an an of or Following cells were for in with and for in with were prepared by the cells in 1 and The were by and to or of proteins was at in a with protein which a anti-phosphotyrosine antibody been of the were with and the proteins were by for in cell or were by and to the in phosphate-buffered saline were with the at for 1 at The were in and with the antibody to for 1 in the proteins were using the system PC12 cells transiently with the or pcDNA-ALK*.Fc) were for in for at with in and with 1 of in containing cells were in the same with an anti-mouse IgG antibody to or cells. with cells were in a To and a anti-SCG10 antibody was to the cells with for 1 at with cells were with an IgG for 1 in and as Because the ALK ligand is we generated a constitutively active form of ALK to the of this receptor. We thus a in which the extracellular domain of ALK was by the mouse IgG 2b Fc domain that we the chimeric protein through formation between residues of the Fc domain. 1 the of the and The pcDNA-ALK.wt construct encodes the wild type receptor (see and below). The pcDNA-ALK.Fc construct for a transmembrane protein that the N-terminal amino of ALK, the Fc fragment and a portion of the extracellular domain amino the and the entire intracellular of The construct for a kinase-defective form of the chimera in which the invariant lysine residue located in the ATP-binding portion of the catalytic domain was changed to (see and This mutation has been to the transforming capability of NPM-ALK (8Bischof D. Pulford K. Mason D.Y. Morris S.W. Mol. Cell. Biol. 1997; 17: 2312-2325Crossref PubMed Scopus (319) Google Scholar). The pcDNA-ALK.wt and the pcDNA-ALK.Fc were transiently expressed in PC12 cells, and the proteins were by and with anti-ALK antibody or anti-mouse IgG both and the receptor as a single 200-kDa in with (5Morris S.W. Naeve C. Mathew P. James P.L. Kirstein M.N. Cui X. Witte D.P. Oncogene. 1997; 14: 2175-2188Crossref PubMed Scopus (412) Google Scholar). In the ALK.Fc protein as a single of and as a of and The is consistent with that of the acid protein by the pcDNA-ALK.Fc whereas the and proteins in to and It is important to that the anti-ALK antibody both the and the ALK.Fc whereas the anti-mouse IgG revealed the ALK.Fc protein. These results that the ALK receptor as a and that the Fc fragment allowed the ALK.Fc chimera to and through PC12 cells transiently the pcDNA-ALK.Fc construct whereas cells the pcDNA-ALK.wt or that were with the vector or the not The were as as and the of the cell at To cells the ALK.Fc protein, was with an anti-mouse in cells with the antibody and were for the neuronal revealed an expression and a of the protein in the of the cells as demonstrated for PC12 cells induced to with R. S. Biol. 1988; PubMed Scopus Google Scholar, R. S. J. Biol. 1997; Full Text Full Text PDF PubMed Scopus Google Scholar). In cells the form of the chimera ALK.Fc to expressed the corresponding protein, as demonstrated by with anti-mouse IgG can that the at the of the cells, suggesting a membrane of the protein. specific was in cells with both the vector or the pcDNA-ALK.wt construct cells transiently with the pcDNA-ALK.Fc construct were in the of of the the process was This indicated that the process was to ALK.Fc receptor dimerization and oligomerization through by or was not by the of in the These results that of ALK.Fc induced neuronal differentiation of PC12 cells. We were to from activation of ALK essentially to neuronal differentiation and not to cell in PC12 cells. However, we from pcDNA-ALK.wt These cells could for the of the ALK and for studies the neurotrophic activity of To the signal transduction involved in the neuronal differentiation process induced by we used the major signaling pathways to The kinase at a of the process induced by ALK.Fc A and In the kinase and the phospholipase Cγ used at their active for effect this process Thus, these that the PC12 neuronal differentiation induced by ALK.Fc the kinase pathway. To determine whether ALK.Fc was and tyrosine signaling cell from PC12 cells transiently with the the or the pcDNA-ALK.Fc were to with a anti-phosphotyrosine and the proteins were by with the same the ALK.Fc protein was highly the protein showed phosphorylation that dimerization oligomerization of the receptor via the Fc fragment induced its most signaling with in the with ALK.Fc To the activation of the kinase by cell from PC12 cells transiently by the the or the pcDNA-ALK.Fc were by with an kinase antibody an antibody with the active of The results in show that the of active of the kinases and were in cell from cells in from and cells. activation of the ALK receptor induced by the Fc fragment to the activation of the kinase pathway. ALK is a novel orphan receptor tyrosine kinase that is essentially and transiently expressed in the nervous system in neuronal suggesting an important role for this receptor during normal development and function of the nervous system. However, the ligand of this receptor has not yet been the normal of ALK still unknown. In it to whether it could as a membrane receptor and whether activation of its kinase activity could neuronal differentiation. To these and to the signal transduction pathways involved in the neurotrophic activity of ALK, we established a model system that allowed us to mimic the normal activation of this receptor. We generated an ALK.Fc chimera containing extracellularly the mouse IgG 2b Fc domain linked to the membrane-spanning segment and the whole cytoplasmic domain of ALK and expressed it PC12 cells. PC12 cells are a used and established in model system for the of neuronal differentiation, can to cells to neurotrophic factors L.A. J. 1994; 14: PubMed Google Scholar). The ALK.Fc chimera expressed in PC12 cells an of which was in with that of the acid protein by the pcDNA-ALK.Fc construct. In with (5Morris S.W. Naeve C. Mathew P. James P.L. Kirstein M.N. Cui X. Witte D.P. Oncogene. 1997; 14: 2175-2188Crossref PubMed Scopus (412) Google Scholar, 6Iwahara T. Fujimoto J. Wen D. Cupples R. Bucay N. Arakawa T. Mori S. Ratzkin B. Yamamoto T. Oncogene. 1997; 14: 439-449Crossref PubMed Scopus (548) Google the wild type ALK as a 200-kDa protein. this to a dimerization and oligomerization of the chimera induced by of the Fc whereas the not or studies showed that ALK.Fc was whereas was that the receptor was To this is the that this has been used to a constitutively activated form of a it could to RTKs but also to of receptors that to as a of their expression of the pcDNA-ALK.Fc construct in PC12 cells, but not of the pcDNA-ALK.wt and induced in a of cells, a between expression of the chimeric receptor and the effect The process was as as consistent with the for expression of the receptor. This process was induced by dimerization and oligomerization of the chimeric receptor, of formation induced by ALK.Fc but not induced by or In to the differentiation, of ALK.Fc induced expression and of the neuronal in a to that induced by R. S. Biol. 1988; PubMed Scopus Google R. S. J. Biol. 1997; Full Text Full Text PDF PubMed Scopus Google Scholar). The that the expression of the form of the chimera not the that the constitutively active form serves as a site for some kinase that could responsible for the effect with The neuronal differentiation induced by the ALK.Fc expression is to the activation of the kinase activity of this for the of the process by ALK.Fc in PC12 cells was by transient expression of the pcDNA-ALK.Fc construct in cells. cells with pcDNA-ALK.Fc expressed of and ALK.Fc chimera PC12 cells but not not It has been that expression of the insulin Schlessinger J. Curr. Biol. 1994; Full Text Full Text PDF PubMed Scopus Google Scholar), epidermal growth factor S. K. H. P. A. Curr. Biol. 1994; Full Text Full Text PDF PubMed Scopus Google Scholar), and growth factor Curr. Biol. 1995; Full Text Full Text PDF PubMed Scopus Google receptors induced neuronal differentiation of PC12 cells when are activated by their In with these of the wild type ALK not neuronal differentiation of PC12 cells, this receptor monomeric and inactive in the of its In the ALK.Fc was these and the of the activation of the tyrosine kinase activity of the RTKs for the neuronal differentiation of PC12 cells. The cytoplasmic that signaling by ALK are unknown. However, analysis of the amino acid sequence of the intracellular portion of ALK revealed sites for binding of such as and (5Morris S.W. Naeve C. Mathew P. James P.L. Kirstein M.N. Cui X. Witte D.P. Oncogene. 1997; 14: 2175-2188Crossref PubMed Scopus (412) Google Scholar). studies with the NPM-ALK revealed a of the fusion protein with and (9Fujimoto J. Shiota M. Iwahara T. Seki N. Satoh H. Mori S. Yamamoto T. Proc. Natl. Acad. Sci. U. S. A. 1996; 93: 4181-4186Crossref PubMed Scopus (246) Google P. C. Morris S.W. J. Mol. Cell. Biol. PubMed Google Scholar). of NPM-ALK that were for binding to and phosphorylation of or could (9Fujimoto J. Shiota M. Iwahara T. Seki N. Satoh H. Mori S. Yamamoto T. Proc. Natl. Acad. Sci. U. S. A. 1996; 93: 4181-4186Crossref PubMed Scopus (246) Google cells, that these signaling are not essential for cell to an important of NPM-ALK that to its activity and is to important in the of anaplastic of this single was to in P. C. Morris S.W. J. Mol. Cell. Biol. PubMed Google Scholar). of the pathways to we that the process the kinase but not the and at the the activation of the kinase the of active of and was to in PC12 cells the pcDNA-ALK.Fc the pcDNA-ALK.wt construct. Thus, these results indicated for the that the kinase can involved in ALK signaling and that it was for the of induced by this receptor. In these of activation of the kinase signaling to essential for the differentiation processes induced by neurotrophic factors in PC12 cells Cell. 1995; Full Text PDF PubMed Scopus Google Scholar). of PC12 cells with or to activation of kinase and to neuronal differentiation 9: Full Text PDF PubMed Scopus Google Scholar). In of the same cells with insulin or transient activation of kinase and not to neuronal differentiation but to cell 9: Full Text PDF PubMed Scopus Google Scholar, 1988; PubMed Scopus Google Scholar, J. Biol. 1997; Full Text Full Text PDF PubMed Scopus Google Scholar, Mol. 1997; Google Scholar). when insulin or receptors were activation of kinase and neuronal differentiation was obtained with the ligands Schlessinger J. Curr. Biol. 1994; Full Text Full Text PDF PubMed Scopus Google S. K. H. P. A. Curr. Biol. 1994; Full Text Full Text PDF PubMed Scopus Google Scholar), that the of receptor expression is for the of a and activation of kinase and neuronal differentiation. In the constitutive activation of ALK.Fc to activation of The that we were to kinase activation as as this the has been to for neuronal differentiation A. R.A. K. A. Schlessinger J. A. EMBO J. 1994; PubMed Scopus Google and has been to required for the from R. Science. 1995; PubMed Scopus Google but not for M. P. Tissue PubMed Scopus Google Oncogene. PubMed Scopus Google by Thus, these results are consistent with that is not involved in the induced by at the or binding site showed in and kinase activation, but at both sites T. L.A. 1994; Full Text PDF PubMed Scopus Google Scholar). These results that both and the kinase and that can for in In with these results to a role of the kinase in and can the of activity with ET-18-OCH3 not the process induced by Therefore, it that activation is for the of the of NPM-ALK (see P. C. Morris S.W. J. Mol. Cell. Biol. PubMed Google but for the neuronal activity of In results showed that activation of the ALK receptor tyrosine kinase to neuronal differentiation and this effect was through the kinase signaling pathway. Thus, these results that ALK could involved in neuronal differentiation and the for a role to We Dr. N. Doyen (Institut Pasteur, for us with the mouse We are to M. for and to A. and R. for the

References

25